New York, June 11, 2024 (GLOBE NEWSWIRE) -- The Global size is expected to reach by 2024 and is further anticipated to reach by 2033 according to Dimension Market Research. The market is anticipated to register a CAGR of from 2024 to 2033. This market is expanding to due growing conditions of obesity and diabetes around the globe.
Devices like syringes, pens, pumps, and jet injectors are medical tools for insulin delivery used by consumers with diabetes to take insulin which controls blood sugar. Insulin pens avoid the need for manual use and are less daunting than syringes, they are anticipated to dominate the market based on product and hold the largest share. This is particularly true for active or traveling patients.
Furthermore, because syringes are readily available and simple to use, the market is predicted to increase at a quick pace. In the context of application, the homecare segment is projected to have the highest market share due to use of modern delivery devices which are highly portable and adopted for self-care diabetes control at home. Moreover, the hospital segment plays a significant role, using devices like pumps and pens for accurate insulin dose and continuous delivery to maintain patients’ insulin level.
Key market players aim to broaden portfolios via collaboration, mergers, and acquisitions, enhancing global presence. They also partner with local firms for expanded market reach. Innovation drives revenue; for example, Novo Nordisk's NoVo Pen Echo of.
